China Biopharma Inc.
(Stock Symbol: CBPC.OB)
is a fast
growing provider of human vaccine
products in China. Through its wholly owned subsidiary, China Biopharma
Limited, the Company owns the majority interest of Zhejiang Tianyuan
Biotech Co., Ltd. The Company's current products consist of human
vaccines against influenza (flu), epidemic hemorrhagic fever (HF), and
Japanese Encephalitis (JE). With its investment and ownership of local
Chinese bio-pharmaceutical companies, the Company plans to build a
leading bio-pharmaceutical company in China by leveraging its
manufacturing and marketing capabilities and introducing advanced
technologies, best products, and experienced management teams. With a
fast growing market, newly completed production facilities, and several
other new vaccines in the pipeline, the Company expects to see steady
business growth in the near future.
-
Company
Presentation
-
SEC Filings
